ASX Release: 23 January 2023 Melbourne, Australia; Acrux Limited (ASX:ACR) Link Here: Acrux today announced that it has concluded an agreement with Gedeon Richter Plc., one of its manufacturing and distribution partners, for Gedeon Richter to buy out the future royalties of Lenzetto® for contracted territories for EUR4.10 million, which at current rates of exchange […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-01-24 23:23:492023-01-24 23:23:49Acrux announces Gedeon Richter buyout of future Lenzetto® royalties for EUR4.1 million
Melbourne, Australia – Link Here: Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce receiving Australian Therapeutic Goods Administration (TGA) approval to commercially distribute its new, next generation Hailie® sensors with physiological parameters. These latest additions to the Hailie sensor product family connect patients […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-01-22 23:35:052023-01-22 23:35:05Adherium receives Australian TGA approval for Next Generation Sensors
11 EXECUTIVES, 55 COMPANIES AND 91 PRODUCTS WIN 2023 BIG INNOVATION AWARD BUSINESS INTELLIGENCE GROUP ANNOUNCES THE WINNERS OF THE 2023 BIG INNOVATION AWARDS Philadelphia, PA— Link Here —Today, the Business Intelligence Group named 11 executives, 55 companies, and 91 products as leaders and winners of the 2023 BIG Innovation Awards. This annual business awards […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2023-01-15 23:33:552023-01-15 23:33:55Canary Medical named a 2023 BIG Innovation Award Winner for Healthcare
Melbourne, Australia – 28 November 2022: (Link Here) Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that is has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market application, connecting GlaxoSmithKline’s (GSK) Ventolin®, Advair®, and Flovent® pressurised metered dose inhaler (pMDI) users with […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2022-11-28 04:25:372022-11-28 04:25:37Adherium receives U.S. FDA 510(k) clearance for GSK pMDI inhaler users to remotely monitor physiological parameters
November 21, 2022 18:52 ET | Source: Graybug Vision, Inc.; CalciMedica Inc. Link here Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica’s pipeline of first-in-class product candidates for life-threatening inflammatory diseases Combined company is expected to be funded with cash and cash equivalents of approximately $35 million at closing, with an expected runway into […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2022-11-22 00:43:432022-11-22 00:43:43Graybug and CalciMedica Enter into Definitive Merger Agreement
The Australian, Tuesday, November 8, 2022, Link Here: One of Australia’s best known, and most successful medical breakthroughs has been the burns treatment process developed in Western Australia, which was highlighted after the 2002 Bali bombings. But it is also one of the most tragic. The US has now embraced the Australian technology as its […]
Melbourne, Australia and London, UK – October 13, 2022 ….. BioScience Managers, the international healthcare investment firm, is pleased to announce the appointment of David Atkins MBA PhD in the role of Managing Partner. Working alongside founder and Managing Partner, Jeremy Curnock Cook, David will be responsible for driving the future growth of BioScience Managers […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2022-10-13 08:56:042022-10-13 08:56:04BioScience Managers Announces the Appointment of Dr. David Atkins as Managing Partner to Continue its Growth in Digital Health
Melbourne, Australia – 21 September 2022 Link here : Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce the appointment of Mr Daniel Kaplon as Chief Financial Officer, effective 10 October 2022. Mr Rick Legleiter, Adherium Chief Executive Officer, commented, “we are very pleased to […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2022-09-21 07:56:472022-09-21 07:56:47Adherium appoints Daniel Kaplon as Chief Financial Officer
Melbourne, Australia – 20 September 2022 Link here : Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce a two-part clinical study at Washington University School of Medicine in St. Louis in the United States to monitor the adherence of Asthma patients using Adherium’s US […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2022-09-21 07:50:432022-09-21 07:50:43Clinical Study involving new Hailie Sensor with Physiological Parameters Launched in U.S.
Melbourne, Australia Link Here – 16 September 2022: Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, has secured subscription commitments from the Company’s Chairman, new and existing institutional and sophisticated investors, including cornerstone investments from existing shareholders Trudell Medical and BioScience Managers Translation Fund […]
/wp-content/uploads/2018/01/BSM_logo.png00victoria/wp-content/uploads/2018/01/BSM_logo.pngvictoria2022-09-20 07:10:202022-09-20 07:10:20Adherium secures A$13.5 million commitment in share and option placement
Acrux announces Gedeon Richter buyout of future Lenzetto® royalties for EUR4.1 million
/in AcruxASX Release: 23 January 2023 Melbourne, Australia; Acrux Limited (ASX:ACR) Link Here: Acrux today announced that it has concluded an agreement with Gedeon Richter Plc., one of its manufacturing and distribution partners, for Gedeon Richter to buy out the future royalties of Lenzetto® for contracted territories for EUR4.10 million, which at current rates of exchange […]
Adherium receives Australian TGA approval for Next Generation Sensors
/in AdheriumMelbourne, Australia – Link Here: Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce receiving Australian Therapeutic Goods Administration (TGA) approval to commercially distribute its new, next generation Hailie® sensors with physiological parameters. These latest additions to the Hailie sensor product family connect patients […]
Canary Medical named a 2023 BIG Innovation Award Winner for Healthcare
/in Canary Medical11 EXECUTIVES, 55 COMPANIES AND 91 PRODUCTS WIN 2023 BIG INNOVATION AWARD BUSINESS INTELLIGENCE GROUP ANNOUNCES THE WINNERS OF THE 2023 BIG INNOVATION AWARDS Philadelphia, PA— Link Here —Today, the Business Intelligence Group named 11 executives, 55 companies, and 91 products as leaders and winners of the 2023 BIG Innovation Awards. This annual business awards […]
Adherium receives U.S. FDA 510(k) clearance for GSK pMDI inhaler users to remotely monitor physiological parameters
/in AdheriumMelbourne, Australia – 28 November 2022: (Link Here) Adherium Limited (“Adherium”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, today announced that is has received U.S. Food and Drug Administration (FDA) 510(k) clearance to market application, connecting GlaxoSmithKline’s (GSK) Ventolin®, Advair®, and Flovent® pressurised metered dose inhaler (pMDI) users with […]
Graybug and CalciMedica Enter into Definitive Merger Agreement
/in CalcimedicaNovember 21, 2022 18:52 ET | Source: Graybug Vision, Inc.; CalciMedica Inc. Link here Merger to create Nasdaq-listed, clinical-stage biopharmaceutical company focused on advancing CalciMedica’s pipeline of first-in-class product candidates for life-threatening inflammatory diseases Combined company is expected to be funded with cash and cash equivalents of approximately $35 million at closing, with an expected runway into […]
Tragedy behind Australia’s world-class burns technology treatment RECELL: Robert Gottliebsen
/in BioSciences ManagersThe Australian, Tuesday, November 8, 2022, Link Here: One of Australia’s best known, and most successful medical breakthroughs has been the burns treatment process developed in Western Australia, which was highlighted after the 2002 Bali bombings. But it is also one of the most tragic. The US has now embraced the Australian technology as its […]
BioScience Managers Announces the Appointment of Dr. David Atkins as Managing Partner to Continue its Growth in Digital Health
/in BioSciences ManagersMelbourne, Australia and London, UK – October 13, 2022 ….. BioScience Managers, the international healthcare investment firm, is pleased to announce the appointment of David Atkins MBA PhD in the role of Managing Partner. Working alongside founder and Managing Partner, Jeremy Curnock Cook, David will be responsible for driving the future growth of BioScience Managers […]
Adherium appoints Daniel Kaplon as Chief Financial Officer
/in AdheriumMelbourne, Australia – 21 September 2022 Link here : Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce the appointment of Mr Daniel Kaplon as Chief Financial Officer, effective 10 October 2022. Mr Rick Legleiter, Adherium Chief Executive Officer, commented, “we are very pleased to […]
Clinical Study involving new Hailie Sensor with Physiological Parameters Launched in U.S.
/in AdheriumMelbourne, Australia – 20 September 2022 Link here : Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions is pleased to announce a two-part clinical study at Washington University School of Medicine in St. Louis in the United States to monitor the adherence of Asthma patients using Adherium’s US […]
Adherium secures A$13.5 million commitment in share and option placement
/in AdheriumMelbourne, Australia Link Here – 16 September 2022: Adherium Limited (“Adherium” or “the Company”; ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, has secured subscription commitments from the Company’s Chairman, new and existing institutional and sophisticated investors, including cornerstone investments from existing shareholders Trudell Medical and BioScience Managers Translation Fund […]